The Asia Pacific Magnetoencephalography Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).
MEG can precisely localize epileptic activity more precisely than any other noninvasive modality can, and it does so without the smearing and blurring that might impair an electroencephalogram (EEG). MEG has an intrinsically high resolution since it utilizes many sensors and is not affected by the skull or scalp in any way. Researchers can localize the neuronal activity to a particular sublobar region, often to a single gyrus or sulcus, when researchers combine MEG with the high-resolution anatomic pictures acquired by MRI. This allows us to pinpoint the precise location of the activity.
MEG helps patients with epilepsy locate the source of their epileptic discharges, and it does so without requiring the placement of electrodes within the patient's skull. When it is necessary to implant intracranial electrodes, magnetic resonance imaging (MEG) may assist in better planning the precise location of the implantation.
MEG technology gives patients undergoing neurosurgery access to helpful information for presurgical mapping in a method that does not involve any intrusive procedures. In addition, MEG technology makes it possible to combine structural and functional information, obtaining high spatial and temporal resolution in the process. This is a combination not presently offered by any other method of researching the brain.
The market for medical equipment in Japan is still significantly reliant on imports, particularly for more technologically advanced medical gadgets. As a result of Japan's rapidly aging demographic profile, there is likely to be a rise in the need for cutting-edge medical technology. Seniors in Japan who have been generally successful throughout their lives have increasingly lofty expectations for the quality of life they will enjoy in their old years. Therefore, there would be widespread acceptance of advances such as magnetoencephalography throughout the country, which would assist the expansion of regional markets.
The China market dominated the Asia Pacific Magnetoencephalography Market by Country in 2021; thereby, achieving a market value of $27,797.6 Thousands by 2028. The Japan market is registering a CAGR of 5% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 6.3% during (2022 - 2028).
Based on Application, the market is segmented into Clinical and Research. Based on Clinical Type, the market is segmented into Epilepsy, Dementia, Autism, Stroke, Multiple Sclerosis, Schizophrenia and Others. Based on End-use, the market is segmented into Hospitals, Academic & Research Institutes and Imaging centres. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Magnetoencephalography Market is Projected to reach USD 350.1 Million by 2028, at a CAGR of 5.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Compumedics Limited, Ricoh Company, Ltd, FieldLine, Inc., MEGIN OY, CTF MEG Neuro Innovations, Inc. and Cerca Magnetics Limited
By Application
By End-use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 